Cosmos Holdings Inc. is a vertically integrated pharmaceutical company. The company is headquartered in Chicago, Illinois.
| Revenue (TTM) | $69.49M |
| Gross Profit (TTM) | $7.23M |
| EBITDA | $-16.50M |
| Operating Margin | -12.20% |
| Return on Equity | -92.30% |
| Return on Assets | -18.70% |
| Revenue/Share (TTM) | $1.96 |
| Book Value | $0.36 |
| Price-to-Book | 0.73 |
| Price-to-Sales (TTM) | 0.19 |
| EV/Revenue | 0.5 |
| EV/EBITDA | -1.60 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 30.70% |
| Shares Outstanding | $52.33M |
| Float | $39.52M |
| % Insiders | 29.03% |
| % Institutions | 5.61% |
Volatility is currently contracting